News & Comment

Many nations provide startup funding for biotech startups. In an effort to give its upstarts an added boost, the Swedish government also plays the role of bridge builder by taking its startups on the road.

Few things are misunderstood more by biotech startup management teams than the importance of creating working space conducive to innovation and productivity, and compatible with the company's vision. Aesthetics, form and function matter.

Life science investors are once again smitten with medical device startups. But, biotech entrepreneurs and investors should keep things in perspective.

Fledgling biotechs and their original investors are increasingly looking at PIPEs to fill the funding void.

In China, biotech startups are struggling to make a go of it. But new models for survival are emerging.

The buzz is growing about reverse mergers as an alternative path to capital markets in the US.

Because of their scale and cost advantages, virtual biotechs are attracting growing interest again. In theory, any element in the innovation chain of a biotech or medical device firm can be outsourced. In practice, the virtual model represents challenges to both investors and management.

The biotech sector is maturing, but investors are still cautious.

New law could provide the long underachieving Argentinean biotech industry the incentives and funding to finally test its potential.

A new panel has been formed in Africa to determine how and where the continent should be building its biotech base.

Despite a faltering biotech IPO market, secondary offerings are still going strong for startups with good news and impeccable timing.

Denmark's next generation of biotech startups needs smart government money and solid VC backing. Is help on the way?

Data suggest that investor exits are dwindling in the US. For now, prospects are rosier in Europe. But, mixed messages are everywhere.

New revelations at the US National Institutes of Health dims any hope of a compromise with scientists and industry.

Startup managers often find themselves interacting in parallel with multiple technology transfer officers. Organizing these collaborations is easier said than done, so we asked four leading authorities how to go about it to enhance the chances of turning a licensed invention into a commercial success.

Some of the world's top scientists and business school graduates are women, so why are so few of them holding senior-level management positions in biotech?

Prince Edward Island is betting that nutraceuticals and stress reduction will give it an edge on the competition.

Wealthy oil nations in the Middle East hope to woo biotech talent and startups with money and other incentives.

The Biotechnology Industry Organization is pushing hard to force the US government to change the rules on certain grants for biotechs. Not everybody views this as a wise pursuit.

Entrepreneurs continue to be stymied by the current climate for IPOs.